The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Regnante Keith since 2018.
This trader's CIK number is 1682068.
At the time of last reporting, Regnante Keith was the Chief Financial Officer of Keros Therapeutics, Inc.. (stock ticker symbol KROS).
Also see all insider trading activities at Keros Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | WVE | 0 | $0 | 1,298 | $47,818 | 0 | $0 |
| 2018 | WVE | 0 | $0 | 29,816 | $1,638,884 | 29,500 | $616,255 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KROS | 0 | $0 | 40,000 | $1,811,600 | 40,000 | $640,000 |
1. Wave Life Sciences Ltd. (WVE)
2. Keros Therapeutics, Inc. (KROS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-19 | WVE | Sale | 1,298 | 36.84 | 47,818 |
| 2018-09-24 | WVE | Sale | 29,500 | 55.00 | 1,622,500 |
| 2018-09-24 | WVE | Option Ex | 29,500 | 20.89 | 616,255 |
| 2018-02-16 | WVE | Sale | 316 | 51.85 | 16,384 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-04 | KROS | Sale | 40,000 | 45.29 | 1,811,600 |
| 2023-11-04 | KROS | Option Ex | 40,000 | 16.00 | 640,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Regnante Keith (Chief Financial Officer of Keros Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.